Night blindness is caused by vitamin A deficiency, congenital mutations, and other eye diseases. Learn about symptoms, causes ...

The funding comes from the Foundation Fighting Blindness' venture philanthropy arm, the Retinal Degeneration Fund.

Objective: To report the functional and morphological outcome of surgical treatment of peripapillary choroidal neovascularisation due to age-related macular degeneration. Methods: Consecutive ...

The OCU410ST Phase 2/3 pivotal confirmatory trial represents a major advancement as Ocugen's second late-stage clinical program. Ocugen plans to submit a BLA for OCU410ST in 2027 in alignment with its ...

Choroidal neovascularisation (CNV) is a common vision-threatening complication of myopia and pathological myopia. Despite significant advances in understanding the epidemiology, pathogenesis and ...

Significant advances have been made in the understanding of the genetics of retinitis pigmentosa (RP), a clinically and genetically heterogeneous group of disorders; ...

Retinitis Pigmentosa Therapeutics Enter New Era as Gene-Agnostic & Intravitreal Therapies Redefine Competitive Landscape. June 04, 2025 03:52 AM AEST | By EIN Presswire. Google News: Image source: EIN ...

We analyzed 23 patients (23 eyes) diagnosed with choroidal melanoma from January 2016 to December 2022 at the Department of Ophthalmology, The First People’s Hospital of Chenzhou, All procedures ...

Retinitis pigmentosa (RP) is a group of genetic eye conditions that leads to incurable blindness.In the progression of symptoms for RP, night blindness generally precedes tunnel vision by years or ...

STGD Stargardt's Disease, PR pigmentosa retinitis, TE total energy, SFA saturated fats, MUFA monounsaturated fats, PUFA polyunstaurated fats, ...

Retinitis pigmentosa (RP), the group of hereditary conditions involving death of retinal photoreceptors, represents the most prevalent cause of visual handicap among working populations in developed ...